Evidence map›Paper›PMID 30723690›Full record

ArticleToxicology reports2019

Acute glufosinate-based herbicide treatment in rats leads to increased ocular interleukin-1β and c-Fos protein levels, as well as intraocular pressure.

Selim Çomaklı, Çiğdem Sevim, George Kontadakis, Elif Doğan, Ali Taghizadehghalehjoughi, Mustafa Özkaraca, Michael Aschner, Taxiarchis Konstantinos Nikolouzakis, Aristides Tsatsakis

Erratum issuedAbstract read
In one paragraph

Article in Toxicology reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Hydroethanolic extract fromToxicology reports · 2020
    Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Selim ÇomaklıDepartment of Veterinary Pathology, Faculty of Veterinary Medicine, Ataturk University, 25240, Erzurum, Turkey.
Çiğdem SevimDepartment of Veterinary Pharmacology and Toxicology, Faculty of Veterinary Medicine, Ataturk University, 25240, Erzurum, Turkey.
George KontadakisLaboratory of Vision and Optics and Ophthalmology Department, School of Medicine, University of Crete, 71003, Heraklion, Greece.
Elif DoğanDepartment of Veterinary Surgery, Faculty of Veterinary Medicine, Ataturk University, 25240, Erzurum, Turkey.
Ali TaghizadehghalehjoughiDepartment of Veterinary Pharmacology and Toxicology, Faculty of Veterinary Medicine, Ataturk University, 25240, Erzurum, Turkey.
Mustafa ÖzkaracaDepartment of Veterinary Pathology, Faculty of Veterinary Medicine, Ataturk University, 25240, Erzurum, Turkey.
Michael AschnerDepartment of Molecular Pharmacology, Albert Einstein College of Medicine, New York, United States.
Taxiarchis Konstantinos NikolouzakisLaboratory of Anatomy‑Histology‑Embryology, Medical School, University of Crete, 71003, Heraklion, Greece.
Aristides TsatsakisLaboratory of Toxicology, School of Medicine, University of Crete, 71003, Heraklion, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glufosinate is a common herbicide with neurotoxic effects, leading to seizures, convulsions and memory loss. Glufosinate indirectly induces glutamate toxicity by inhibiting glutamine synthesis in astrocytes. Here, we studied the acute toxic effects of a glufosinate-based herbicide in rat optic nerve at three doses (40, 80 or 120 μM, equal to 714 or 21 mg/kg bw/day). Serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), urea, glucose, calcium, as well as creatinine concentrations were analyzed after 24, 48 and 72 h treatment. Intraocular pressure (IOP) (expressed as the average of both eyes) was measured with a rebound tonometer. Interleukin-1β (IL-1β) and c-Fos expression were determined by immunohistochemistry. The results established that the glufosinate-based herbicide significantly increased IL-1β and c-Fos immunopositivity in the optic nerve (p < 0.05), concomitant with increased IOP. These results suggest that commercial formulations of glufosinate acutely affect the optic nerve.

Indexed as

c-fosGlufosinateInterleukin-1βIntraocular pressure

Identifiers

PMID30723690
PMCPMC6351388

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.